Application

17847588 · AMORPHOUS SOLID FORM OF COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND SODIUM CATIONS

Filed 2022-06-23 · Granted · Patent 11642329 (2023-05-09) The official file ↗The patent and its PDF ↗ · Art unit 1611 · Examiner Timothy P Thomas Hard · CPC A61K 31/216 · Novartis Pharmaceuticals Corporation · NOVARTIS PHARMACEUTICAL CORPORATION

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

4.9 mo

to disposition 10.5 mo

Statutes raised

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.